Feng Chi Biotech Corp.

NT$12.25As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6744Healthcare
Country Taiwan
PE (Fwd) •••
TSR 7Y CAGR (9.20%)
Div yield 6.86%
ROE 4.28%
Biotechnology
Beta (5Y) 0.32
PE TTM 19.05
TSR TTM (33.03%)
Mkt cap NT$188.7M
ROIC 10.06%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$12
1.42%
(63.28%)
Hold 1|9|5|0|9
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.24
0.25
0.28
0.28
23.05%
29.13%
38.81%
28.55%
RevenueNT$M
10.09
9.899
9.646
9.383
(5.14%)
(4.83%)
(5.69%)
(7.48%)
Peers (US$5.675M)
Cap (US$)
PE
8.881M
14.01x
6.746M
—
5.651M
1.763x
Capital
TTM
5Y
10Y
Leveragex
0.068
0.962
0.920
EBIT/Intx
7.977
0.525
0.438
Own earn%
126.55
(38.45)
(28.47)
Sh yield%
50.63
53.15
53.64
Owners
Insiders/Inst%
4.15
82.12
Short interest%
2.03
SBC / revenue%
1.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
6–10
$1 testx
0.1
Incr. ROIC%
1